Surmodics to Participate in the Piper Sandler Healthcare Conference on November 28
14 Novembro 2023 - 6:05PM
Business Wire
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical
device and in vitro diagnostic technologies to the healthcare
industry, today announced that management will participate in the
35th Annual Piper Sandler Healthcare Conference, which is being
held at the Lotte New York Palace in New York, NY from November
28-30, 2023. Management will present on Tuesday, November 28, at
8:30 a.m. ET (7:30 a.m. CT).
A live webcast of the presentation can be accessed by going to
“Events & Presentations” under the “Investors” section of the
company’s website at
https://surmodics.gcs-web.com/events-and-presentations, and
clicking on the webcast icon under “Upcoming Events.” A replay of
the webcast will be archived on the website for the following 90
days.
About Surmodics, Inc.
Surmodics is a leading provider of performance coating
technologies for intravascular medical devices and chemical and
biological components for in vitro diagnostic immunoassay tests and
microarrays. Surmodics also develops and commercializes highly
differentiated vascular intervention medical devices that are
designed to address unmet clinical needs and engineered to the most
demanding requirements. This key growth strategy leverages the
combination of the Company’s expertise in proprietary surface
modification and drug-delivery coating technologies, along with its
device design, development, and manufacturing capabilities. The
Company’s mission is to improve the detection and treatment of
disease. Surmodics is headquartered in Eden Prairie, Minnesota. For
more information, visit www.surmodics.com. The content of
Surmodics’ website is not part of this press release or part of any
filings that the company makes with the Securities and Exchange
Commission.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231114314459/en/
Surmodics Investor Inquiries: Jack Powell, Investor Relations
ir@surmodics.com
SurModics (NASDAQ:SRDX)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
SurModics (NASDAQ:SRDX)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024